Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 22, 2009

Premium

The board of directors of BioNanomatrix has tapped Edward Erickson to take over as CEO and president of the company. Erickson, who was previously executive chairman of the board, takes over the post from Michael Boyce-Jacino. Tracey Warren, general partner at Battelle Ventures, will succeed Erickson as chairperson. Erickson has served as a director at BioTrove and at Barrier Therapeutics.


Lynn L'Archeveque has recently joined Schott as the US east coast sales manager for its Nexterion microarray products.

Prior to joining Schott, L'Archeveque worked in business development at NextBio and Biocompare.


Sequenom has appointed Kenneth Buechler and David Pendarvis to its board of directors. Buechler previously was president, chief scientific officer, and co-founder of Biosite. Pendarvis is senior vice president of organizational development, global general counsel, and secretary of ResMed.


Robert Langer has been named to Millipore's board of directors, where he will take the place of exiting director Daniel Bellus. Langer is the David H. Koch Institute Professor at the Massachusetts Institute of Technology. He also serves on the board of MIT's McGovern Institute and Whitehead Institute.


Regis Technologies has named four new members to its scientific staff, all former employees at DeCode Genetics. The appointments include Nelson Zhao, Igor Likhotvorik, Sied Zegar, and Dragan Ristic, all of which are from DeCode's development and production staff.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.